ArticleNeuro-oncology2014

Association of matrix metalloproteinase 2 plasma level with response and survival in patients treated with bevacizumab for recurrent high-grade glioma.

Emeline Tabouret et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.